Nvidia, Sheba Medical Center in Israel, and Mount Sinai Hospital in the United States have launched a major collaboration to use artificial intelligence in decoding the vast portions of the human genome that remain mysterious. The project, backed by tens of millions of dollars, will combine Sheba's clinical data, Nvidia's computing power and AI expertise, and Mount Sinai's extensive genetic data from its 'Million Genomes' project. The goal is to develop advanced language models to better understand gene regulation and its impact on health, paving the way for breakthroughs in disease prevention, diagnosis, and personalized medicine.

Leaders from Sheba emphasize that this initiative places them at the forefront of scientific and medical innovation, with the potential to transform diagnostics and drug development. While the resulting model will be publicly available, Sheba and Mount Sinai will retain intellectual property rights for discoveries made. The project also highlights the need for greater investment in Israel's medical and digital infrastructure to fully realize the benefits of artificial intelligence in healthcare.